ANDA 40423, held by Nesher Pharms. Prednisolone.
As of Nov 15, 2026, ANDA 40423 (Prednisolone), held by Nesher Pharms, was first approved by FDA on Oct 22, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 22, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone5MG/5ML ยท syrup;oral | Prednisolone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
